Sigachi Industries Ltd
SIGACHISigachi Industries Ltd
SIGACHIPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
25.45 | 3.81 | 0.20% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
29.41 | 3.34 | 1.39% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sigachi Industries Private Limited is an India-based company that manufactures cellulose-based excipients. The Company manufactures microcrystalline cellulose (MCC), the polymer used for finished dosages in the pharmaceutical industry.
Investor Presentation
View olderPeers
Compare with peersSolar Industries India Ltd
Linde India Ltd
Deepak Nitrite Ltd
Himadri Speciality Chemical Ltd
Sumitomo Chemical India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 103.78 | 132.88 | 143.95 | 196.01 | 252.92 | 308.72 | 410.65 | 460.96 | ||||||||
Raw Materials | 60.65 | 70.25 | 74.03 | 97.91 | 123.47 | 142.36 | 200.28 | 358.52 | ||||||||
Power & Fuel Cost | 3.71 | 4.08 | 4.11 | 4.40 | 5.44 | 6.62 | 10.27 | |||||||||
Employee Cost | 7.73 | 10.18 | 11.71 | 13.93 | 16.55 | 32.23 | 50.33 | |||||||||
Selling & Administrative Expenses | 9.90 | 12.02 | 15.34 | 20.64 | 41.14 | 46.58 | 44.32 | |||||||||
Operating & Other expenses | 7.01 | 6.50 | 9.11 | 17.09 | 10.65 | 15.53 | 17.11 | |||||||||
EBITDA | 14.78 | 29.85 | 29.65 | 42.04 | 55.67 | 65.40 | 88.34 | 102.44 | ||||||||
Depreciation/Amortization | 1.39 | 1.67 | 1.96 | 2.31 | 2.90 | 6.63 | 10.80 | 12.68 | ||||||||
PBIT | 13.39 | 28.18 | 27.69 | 39.73 | 52.77 | 58.77 | 77.54 | 89.76 | ||||||||
Interest & Other Items | 3.79 | 3.45 | 2.34 | 1.25 | 1.17 | 4.29 | 7.77 | 9.97 | ||||||||
PBT | 9.60 | 24.73 | 25.35 | 38.48 | 51.60 | 54.48 | 69.77 | 79.79 | ||||||||
Taxes & Other Items | 2.68 | 5.72 | 5.02 | 8.22 | 11.56 | 54.48 | 12.60 | 13.70 | ||||||||
Net Income | 6.92 | 19.01 | 20.33 | 30.26 | 40.04 | 0.00 | 57.17 | 66.09 | ||||||||
EPS | 0.03 | 0.08 | 0.09 | 0.13 | 0.31 | 0.00 | 1.80 | 2.01 | ||||||||
DPS | 0.01 | 0.01 | 0.03 | 0.00 | 0.10 | 0.10 | 0.10 | 0.10 | ||||||||
Payout ratio | 0.44 | 0.16 | 0.38 | 0.00 | 0.33 | 14,42,20,74,11,92,122.38 | 0.06 | 0.05 |
Company Updates
Investor Presentation
Peers & Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sigachi Industries Ltd | 29.43 | 3.81 | 0.20% |
Solar Industries India Ltd | 110.58 | 26.97 | 0.08% |
Linde India Ltd | 121.54 | 15.21 | 0.19% |
Deepak Nitrite Ltd | 43.25 | 7.27 | 0.29% |
Price Comparison
Compare SIGACHI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 2.00%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Sigachi Industries Ltd
Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Bandhan BSE Healthcare Index Fund Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 87/102 (+6) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 28, 2024
Dividend/Share
₹0.10
Ex DateEx Date
Aug 28, 2024
Cash Dividend
Ex DateEx DateAug 31, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Aug 31, 2023
Cash Dividend
Ex DateEx DateAug 2, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2022
Achieving the Certificate of Suitability (CEP) for this API will enable the company to export this product in Europe and other CEP accepting countries. Propafenone Hydrochloride, widely used in the treatment of cardiac arrhythmias, is a high demand API with a current global market size of $1.2 billion. 'The market is poised for robust growth, with projections reaching $ 2.1 billion by 2032, reflecting a CAGR of 7% over the forecast period. This growth is driven by the increasing prevalence of cardiovascular diseases, growing adoption of generic medications, and rising healthcare expenditure globally,' the company stated in regulatory filing. Amit Raj Sinha, managing director and CEO of Sigachi Industries, said, 'The submission of our first CEP filing is a testament to Trimax Biosciences' commitment to quality, compliance, and innovation in the API domain. This achievement not only strengthens our position in the pharmaceutical supply chain but also aligns with our vision of providing reliable and sustainable pharmaceutical solutions on a global scale.' Telangana based Sigachi Industries is engaged in manufacturing of microcrystalline cellulose (MCC), which is widely used in pharmaceutical, food, beverage, cosmetic and paint industry. The most common uses of MCC are in vitamin supplements and tablets. It also acts as a bulking agent in food production. MCC is produced from refined wood pulp which is imported by the company. The company's consolidated net profit jumped 43.8% to Rs 21.78 crore on 25.9% increase in net sales to Rs 124.90 crore in Q2 FY25 over Q2 FY24.Powered by Capital Market - Live
Sigachi Industries announced about its recent submission of CEP filing for 'Propafenone Hydrochloride'. This is a significant step towards ensuring European regulatory standards and highest levels of product quality and safety. It will also strategically diversify Sigachi's revenue channels to enhance greater value for all stakeholders involved Propafenone Hydrochlride, widely used in the treatment of cardiac arrhythmias, is a highdemand API with a current global market size of USD 1.2 billion. Powered by Capital Market - Live
Sigachi Industries announced the resignation of Sarweswara Reddy Sanivarapu (DIN: 00459605) as Chairman of the Board and Independent Director of the Company on 25 November 2024. Powered by Capital Market - Live
Net profit of Sigachi Industries rose 43.76% to Rs 21.78 crore in the quarter ended September 2024 as against Rs 15.15 crore during the previous quarter ended September 2023. Sales rose 25.93% to Rs 124.90 crore in the quarter ended September 2024 as against Rs 99.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales124.9099.18 26 OPM %13.7921.59 - PBDT29.7720.74 44 PBT26.5518.21 46 NP21.7815.15 44 Powered by Capital Market - Live
Sigachi Industries has revised the meeting of the Board of Directors which was scheduled to be held on 8 November 2024. The meeting will now be held on 13 November 2024.Powered by Capital Market - Live
Sigachi Industries has revised the meeting of the Board of Directors which was scheduled to be held on 8 November 2024. The meeting will now be held on 13 November 2024.Powered by Capital Market - Live
Sigachi Industries will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Sigachi Industries has allotted 52,52,190 equity shares of Re. 1/- each to non-promoters at an issue price of Rs. 26.1/- per share upon conversion of 52,52,190 (pre split - 5,25,219) warrants into equity shares. Powered by Capital Market - Live
Sigachi Industries will hold a meeting of the Board of Directors of the Company on 30 August 2024.Powered by Capital Market - Live
Sigachi Industries announced that the Annual General Meeting (AGM) of the company will be held on 4 September 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 25.31%, vs industry avg of 9.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.18% to 0.35%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 24.63%, vs industry avg of 4.66%